Lopez, M. E., Wendt, D., Lawrence, R., Gong, K., Ong, H., Yip, B., Chen, J., Mangini, L., Handyside, B., Giaramita, A., Lamichhane, A., Lo, M., Agrawal, V., Vleet, J. V., Abolhesn, A., Felix, J. B., Villalpando, I., Bhat, V., Angelis, R. D., Ru, Y., Khan, A., Fong, S., Christianson, T., Bullens, S., Crawford, B. E., Bunting, S., Aoyagi-Scharber, M. (2025). Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model. PLoS ONE. https://doi.org/10.1371/journal.pone.0315005